Notice Title

Consent to the Distribution of New Medicines

Publication Date
29 Jun 2023

Tags

Medicines Act Consent to the distribution of new medicines Health

Notice Number

2023-go2807
Title
View PDF
File Type and Size
PDF (34 KB)

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product: Pemetrexed Dr. Reddy’s
Active Ingredient: Pemetrexed disodium 551.4mg equivalent to pemetrexed 500mg
Dosage Form: Powder for infusion
New Zealand Sponsor: Dr Reddy’s New Zealand Limited
Manufacturer: Dr Reddy’s Laboratories Limited, Visakhapatnam, India
   
Product: Rinvoq
Active Ingredient: Upadacitinib hemihydrate 46.1mg equivalent to upadacitinib 45mg
Dosage Form: Modified release tablet
New Zealand Sponsor: AbbVie Limited
Manufacturer: AbbVie Ireland NL B.V., Sligo, Ireland


Dated this 23rd day of June 2023.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).